A new study has linked the use of psilocybin with a reduction in the likelihood of an individual engaging in criminal behavior. Psilocybin is the active compound found in hallucinogenic mushrooms.
Harvard University clinical psychology PhD candidate Grant Jones, the author of the study, stated that his interest in psychedelics grew as the substances gained more attention because of their treatment potential, having demonstrated that they could be used to relieve a number of mental health conditions. Jones explained that the purpose of the research was to investigate the relationship between criminality and psychedelics using population-based survey data, because not many studies on this had been done.
The researchers were especially interested in finding the link between reduced criminal behavior and the use of psychedelics, explaining that prior studies only looked into the link between crime arrests and classic psychedelics as a group.
For their own study, the researchers sought to investigate the link between crime arrest outcomes and a number of classic psychedelic compounds, including mescaline, peyote, LSD and psilocybin. They used data obtained from the National Survey on Drug Use and Health survey, which gathers information on mental health outcomes and drug use in the United States annually.
The researchers conducted an analysis of this data, which comprised of a sample made up of more than 211,000 adults who filled out the survey in the period between 2015 and 2019. The survey asked respondents if they had been arrested for burglary, larceny, robbery, motor vehicle theft, serious violent offenses, assault/battery, possession of stolen goods, fraud, vandalism, public drunkenness, drug possession/sale and DUIs, among other crimes.
The researchers discovered that individuals who used psilocybin reported lower odds of being arrested for DUIs, serious violence, assault/battery, robbery, burglary, larceny and miscellaneous crimes. The use of peyote was also linked to lower rates of being arrested for DUIs and motor vehicle theft.
The researchers also found that LSD was the most commonly used drug, noting that its use wasn’t associated with criminal arrests. However, the use of marijuana, cocaine and heroin was linked to significantly higher chances of criminal arrests.
The study’s findings offer evidence that the use of psilocybin corresponds to lower chances of criminal arrest, even after accounting for a number of demographic factors, including level of education, class and race. In their report, the researchers highlight that the findings should be viewed as a preliminary link between lower chances of criminal arrests and the use of psilocybin, noting that more research is needed to better understand this association.
The study’s findings were reported in the “Journal of Psychopharmacology.”
The findings of this study aren’t surprising to a large extent, given the many beneficial effects being documented about psilocybin and how companies such as Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) are devoting significant time and funds towards developing therapeutic products from this and other psychedelic compounds in a bid to address the treatment needs of people battling addiction and other mental health issues.
NOTE TO INVESTORS: The latest news and updates relating to Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) are available in the company’s newsroom at https://ibn.fm/MYCOF
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.PsychedelicNewsWire.com
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire is part of the InvestorBrandNetwork.